| Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis |
73 |
| Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association |
73 |
| Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes |
42 |
| Neutrophil Extracellular Traps Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis |
42 |
| Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1 and Cathepsin G |
41 |
| Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council |
35 |
| Plasma Ceramides: A Novel Predictor of Major Adverse Cardiovascular Events After Coronary Angiography |
32 |
| Vascular Smooth Muscle Cell Plasticity and Autophagy in Dissecting Aortic Aneurysms |
31 |
| Novel Role of IL (Interleukin)-1 beta in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms |
27 |
| Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein) |
26 |
| Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration |
25 |
| Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe(-/-) Mice |
25 |
| miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase) |
24 |
| Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis |
24 |
| Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation Involvement of Vitamin K-Dependent Processes |
23 |
| Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry |
23 |
| Smooth Muscle Cell Phenotypic Diversity At the Crossroads of Lineage Tracing and Single-Cell Transcriptomics |
22 |
| Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT an Antiplatelet GPVI (Glycoprotein VI) Fab First-in-Human Healthy Volunteer Trial |
22 |
| Endothelial-Specific Cre Mouse Models: Is Your Cre CREdibile? |
20 |
| From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease |
19 |
| Flavorings in Tobacco Products Induce Endothelial Cell Dysfunction |
19 |
| Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension |
19 |
| -5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators |
19 |
| Novel Antiatherosclerotic Therapies |
19 |
| PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation |
19 |
| Atherosclerosis in Chronic Kidney Disease More, Less, or Just Different? |
18 |
| Inhalation of Fine Particulate Matter Impairs Endothelial Progenitor Cell Function Via Pulmonary Oxidative Stress |
18 |
| SM22 alpha (Smooth Muscle 22 alpha) Prevents Aortic Aneurysm Formation by Inhibiting Smooth Muscle Cell Phenotypic Switching Through Suppressing Reactive Oxygen Species/NF-kappa B (Nuclear Factor-kappa B) |
18 |
| Nanoparticle Therapy for Vascular Diseases |
18 |
| Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages |
18 |
| Role of ADAMTS-5 in Aortic Dilatation and Extracellular Matrix Remodeling |
18 |
| IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14) |
17 |
| HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population A Case-Control Study From the PREVEND Cohort |
17 |
| MicroRNA-Mediated Therapy Modulating Blood-Brain Barrier Disruption Improves Vascular Cognitive Impairment |
17 |
| Impact of miRNA in Atherosclerosis |
16 |
| Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases |
16 |
| Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque The Multi-Ethnic Study of Atherosclerosis |
16 |
| DKK3 (Dickkopf 3) Alters Atherosclerotic Plaque Phenotype Involving Vascular Progenitor and Fibroblast Differentiation Into Smooth Muscle Cells |
16 |
| Osteopontin in Vascular Disease Friend or Foe? |
16 |
| Inhibition of Mitochondrial Oxidative Damage Improves Reendothelialization Capacity of Endothelial Progenitor Cells via SIRT3 (Sirtuin 3)-Enhancec SOD2 (Superoxide Dismutase 2) Deacetylation in Hypertension |
16 |
| Ly6C(Hi) Blood Monocyte/Macrophage Drive Chronic Inflammation and Impair Wound Healing in Diabetes Mellitus |
16 |
| Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases |
16 |
| Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques |
15 |
| Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation |
15 |
| nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe(-/-) Mice |
15 |
| Multifaceted Mechanisms of Vascular Calcification in Aging |
15 |
| Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research |
15 |
| Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections Old Controversies and New Opportunities |
15 |
| Epidemiology of Vascular Dementia Nosology in a Time of Epiomics |
15 |
| Contact Activation Inhibitor and Factor XI Antibody, AB Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial |
15 |
